Dual excitation-wavelength-dependent luminescence and proton transfer in ESIPT-active zinc(ii) complexes with 2-(1H-pyrazol-1-yl)-4-(2-hydroxyphenyl)pyrimidine

Abstract

Dinuclear ESIPT-active complexes, [Zn2(HL)2X4] (X = Cl, Br, I), based on 2-(1H-pyrazol-1-yl)-4-(2-hydroxyphenyl)pyrimidine (HL), have been synthesized. Along with an ESIPT site with a short O–H⋯N hydrogen bond (O⋯N distance: 2.6 Å), the HL ligand molecule features an additional N,N-chelating site as a prerequisite for metal coordination. This dual-site architecture of the ligand molecule has become a key precondition for the design of ESIPT-active metal complexes, as it ensures the coordination of metal ions to the N,N-chelating site while preserving the integrity of the ESIPT site during complex formation. In the solid state, the ESIPT-active zinc(II) complexes exhibit dual excitation-wavelength-dependent emission as a result of the interplay of a phosphorescence band in the orange region and a fluorescence band in the green region. According to TDDFT calculations, the dependence of photoluminescence on excitation energy stems from the coexistence of two minima on the potential energy surface of the S0 state, corresponding to enol (E) and keto (K) forms. Excitation with high-energy photons (λex = 300–400 nm) facilitates population of the S1 state in the enol form, i.e., S0E → S1, followed by intersystem crossing S1 → T1 and subsequent phosphorescence T1E → S0. Conversely, low-energy photons (λex > 420 nm) selectively excite molecules in the keto form, S0K → S1, leading to S1K → S0 fluorescence.

Graphical abstract: Dual excitation-wavelength-dependent luminescence and proton transfer in ESIPT-active zinc(ii) complexes with 2-(1H-pyrazol-1-yl)-4-(2-hydroxyphenyl)pyrimidine

Supplementary files

Article information

Article type
Paper
Submitted
17 Jul 2025
Accepted
08 Sep 2025
First published
09 Sep 2025

Dalton Trans., 2025, Advance Article

Dual excitation-wavelength-dependent luminescence and proton transfer in ESIPT-active zinc(II) complexes with 2-(1H-pyrazol-1-yl)-4-(2-hydroxyphenyl)pyrimidine

N. A. Shekhovtsov, S. N. Vorobyeva, A. A. Ryadun, E. B. Nikolaenkova, A. Y. Tikhonov and M. B. Bushuev, Dalton Trans., 2025, Advance Article , DOI: 10.1039/D5DT01688F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements